Wednesday, June 22, 2011
Manpower planning and allocation in MSMEs - Lateral Strategy
Article published in June 2011 issue of TISA.
Thursday, June 9, 2011
New Age Challenges, A Test for SMEs: Pharma Sector Poised to Grow
Indian pharmaceutical sector is on the threshold of growth in multifarious areas. Owing to changes in regulations and opening up of the sector as part of globalization, the country is on the 'most-wanted' list of many international pharmaceutical giants.
Indian pharma sector is growing at the rate of approximately 8-9% and is presently considered to be ranked 14th in terms of value. This ranking is predicted to go up in this decade and India is expected to become a lucrative market in the coming years due to many complementing factors. At present selected few companies like Cipla, Sun Pharma, Ranbaxy, Lupin, Dr. Reddy's Labs etc. have a formidable presence in the overall domestic market share and have considerable exports. There are around 250 – 300 large units and more than 8000 small scale units. But there is a huge scope for growth in this country owing to its massive population, majority of them are still bereft of basic medication and healthcare.
Published in SME World June 2011 Issue
Indian pharma sector is growing at the rate of approximately 8-9% and is presently considered to be ranked 14th in terms of value. This ranking is predicted to go up in this decade and India is expected to become a lucrative market in the coming years due to many complementing factors. At present selected few companies like Cipla, Sun Pharma, Ranbaxy, Lupin, Dr. Reddy's Labs etc. have a formidable presence in the overall domestic market share and have considerable exports. There are around 250 – 300 large units and more than 8000 small scale units. But there is a huge scope for growth in this country owing to its massive population, majority of them are still bereft of basic medication and healthcare.
Published in SME World June 2011 Issue
Opportunities & SMEs: “India Can Become Global Pharma Hub”
An Interview with Pharma Analyst Mr. Prashant Vaishampayan.
The Pharma stocks are also performing well in case of Mutual Funds. A review of fund category returns in the last five years places Equity: Pharma at 12.78% returns second only to Equity Banking which tops the list.
Published in SME World June 2011 Issue
The Pharma stocks are also performing well in case of Mutual Funds. A review of fund category returns in the last five years places Equity: Pharma at 12.78% returns second only to Equity Banking which tops the list.
Published in SME World June 2011 Issue
Innovation Strategies for SMEs
The entrepreneurial zeal of one person or a group of people trigger the birth of an enterprise. Once the business has been setup, it requires continuous monitoring and evolving strategies to keep it competitive and on the growth path. Most enterprises which have become successful and are growing today are those which have been able to do something different. The element that segregates them from the crowd is Innovation.
The article has been published in the 2nd Issue of SME Connect by SME Chamber of India.
Original Link: 2nd Issue of SME Connect Page 34
The article has been published in the 2nd Issue of SME Connect by SME Chamber of India.
Original Link: 2nd Issue of SME Connect Page 34
Monday, May 16, 2011
Assimilating Product Life Cycle and Marketing Mix
A short discourse on understanding the product life cycle and implementing an appropriate marketing mix to support the product at each stage and elongate the life.
The article was published in the May Issue of TISA.
The article was published in the May Issue of TISA.
Tuesday, May 10, 2011
Withering Heights: SMEs Wilting Under LE Dominance
Published in May 2011 Issue of SME World.
Most businesses have evolved from the entrepreneurial initiatives of one individual or a group of people. The idea behind such initiative is either an innovative product/ service to fill a gap in the market or a banal copy of an existing one with or without a twist. But whatever be the germinating reason, an enterprise does not become a large company from day one unless it is the sister concern of an established large enterprise. Companies have to go through the stages of small, medium and then become large albeit with different rate of growth for each company. Today, though we are constantly berating government and industry policies, banking norms, economic reform measures etc., for the stunted growth of the biggest employment generation segment – small and medium enterprises; it is the large enterprises that are significantly instrumental in impeding the growth in more ways than one. This article aims to look at the various spheres where large industries' (LEs) clout is wilting the SMEs.
Click here to read the entire article
Most businesses have evolved from the entrepreneurial initiatives of one individual or a group of people. The idea behind such initiative is either an innovative product/ service to fill a gap in the market or a banal copy of an existing one with or without a twist. But whatever be the germinating reason, an enterprise does not become a large company from day one unless it is the sister concern of an established large enterprise. Companies have to go through the stages of small, medium and then become large albeit with different rate of growth for each company. Today, though we are constantly berating government and industry policies, banking norms, economic reform measures etc., for the stunted growth of the biggest employment generation segment – small and medium enterprises; it is the large enterprises that are significantly instrumental in impeding the growth in more ways than one. This article aims to look at the various spheres where large industries' (LEs) clout is wilting the SMEs.
Click here to read the entire article
Wednesday, April 27, 2011
Subscribe to:
Posts (Atom)